Sartorius Stedim Biotech Statistics

Total Valuation

LON:0RG8 has a market cap or net worth of GBP 16.44 billion. The enterprise value is 18.28 billion.

Market Cap	16.44B
Enterprise Value	18.28B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Apr 2, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+5.01%
Shares Change (QoQ)	-0.91%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.74M

Valuation Ratios

The trailing PE ratio is 113.55.

PE Ratio	113.55
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.17, with an EV/FCF ratio of 46.50.

EV / Earnings	126.22
EV / Sales	7.95
EV / EBITDA	34.17
EV / EBIT	57.06
EV / FCF	46.50

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.71.

Current Ratio	1.85
Quick Ratio	1.05
Debt / Equity	0.71
Debt / EBITDA	4.38
Debt / FCF	6.04
Interest Coverage	2.68

Financial Efficiency

Return on equity (ROE) is 5.33% and return on invested capital (ROIC) is 3.74%.

Return on Equity (ROE)	5.33%
Return on Assets (ROA)	3.10%
Return on Invested Capital (ROIC)	3.74%
Return on Capital Employed (ROCE)	5.41%
Revenue Per Employee	232,196
Profits Per Employee	14,625
Employee Count	9,901
Asset Turnover	0.35
Inventory Turnover	2.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.31% in the last 52 weeks. The beta is 0.72, so LON:0RG8's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	-19.31%
50-Day Moving Average	202.22
200-Day Moving Average	184.04
Relative Strength Index (RSI)	44.08
Average Volume (20 Days)	47,305

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RG8 had revenue of GBP 2.30 billion and earned 144.80 million in profits. Earnings per share was 1.50.

Revenue	2.30B
Gross Profit	997.90M
Operating Income	327.48M
Pretax Income	181.27M
Net Income	144.80M
EBITDA	520.41M
EBIT	327.48M
Earnings Per Share (EPS)	1.50

Full Income Statement

Balance Sheet

The company has 569.62 million in cash and 2.37 billion in debt, giving a net cash position of -1.80 billion.

Cash & Cash Equivalents	569.62M
Total Debt	2.37B
Net Cash	-1.80B
Net Cash Per Share	n/a
Equity (Book Value)	3.33B
Book Value Per Share	33.88
Working Capital	663.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 674.06 million and capital expenditures -281.00 million, giving a free cash flow of 393.06 million.

Operating Cash Flow	674.06M
Capital Expenditures	-281.00M
Free Cash Flow	393.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 43.41%, with operating and profit margins of 14.24% and 6.30%.

Gross Margin	43.41%
Operating Margin	14.24%
Pretax Margin	7.88%
Profit Margin	6.30%
EBITDA Margin	22.64%
EBIT Margin	14.24%
FCF Margin	17.10%

Dividends & Yields

This stock pays an annual dividend of 0.59, which amounts to a dividend yield of 0.29%.

Dividend Per Share	0.59
Dividend Yield	0.29%
Dividend Growth (YoY)	-53.44%
Years of Dividend Growth	n/a
Payout Ratio	38.32%
Buyback Yield	-5.01%
Shareholder Yield	-4.72%
Earnings Yield	0.88%
FCF Yield	2.39%

Dividend Details

Stock Splits

The last stock split was on May 6, 2016. It was a forward split with a ratio of 6.

Last Split Date	May 6, 2016
Split Type	Forward
Split Ratio	6

Scores

LON:0RG8 has an Altman Z-Score of 3.8.

Altman Z-Score	3.8
Piotroski F-Score	n/a